Terazosin hydrochloride
Synonym(s):1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride;1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate;Terazosin hydrochloride dihydrate
- CAS NO.:63074-08-8
- Empirical Formula: C19H26ClN5O4
- Molecular Weight: 423.9
- MDL number: MFCD00467965
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 15:53:33
What is Terazosin hydrochloride?
Description
Terazosin hydrochloride is a highly water-soluble antihypertensive agent with a structure and profile closely related to that of prazosin.
Originator
Abbott (USA)
The Uses of Terazosin hydrochloride
Terazosin hydrochloride has been used for orthogonality and similarity analysis using reversed-phase chromatographic studies5. Furthermore, terazosin has also been used for the evaluation of chemometric techniques to determine orthogonality and similarity in chromatographic methods6.
The Uses of Terazosin hydrochloride
Hytrin (Abbott).
The Uses of Terazosin hydrochloride
An α-1-adrenergicblocker related to prazosin.
What are the applications of Application
Terazosin hydrochloride is an α1- and α2B-adrenoceptor antagonist
brand name
Terazosin is INN and BAN;HEITRIN.
General Description
Terazosin hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride (Hytrin), is a structuralcongener of prazosin hydrochloride. It possessessimilar selective properties of specifically inhibiting 1-adrenergic receptors. The drug is slightly less potent thanprazosin hydrochloride. Terazosin hydrochloride has a halflifeof approximately 12 hours, which is much longer thanthat of prazosin. This lends itself to a once-daily dose tocontrol hypertension in many patients.
Biological Activity
α 1 - and α 2B -adrenoceptor antagonist (K i values are 3.3, 0.7, 1.1, 7.7, 1510 and 78.2 nM for α 1A , α 1B , α 1D , α 2B , α 2A and α 2C receptors respectively). Antihypertensive following oral or intravenous administration in vivo .
Biochem/physiol Actions
α1-adrenoceptor antagonist.
storage
Store at RT
References
References/Citations 1) Hancock et al. (1995), Actions of terazosin and its enantiomers at subtypes of alpha-1 and alpha-2 adrenoceptors in vitro; Recept. Signal Transduct. Res., 15 863 2) Kyncl et al. (1986), Pharmacology of terazosin; Am. J. Med., 80 12 3) Shionoiri et al. (1994), Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study; Am. J. Med. Sci., 307 Suppl 1 S91 4) Pan et al. (2003), Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells; J. Urol., 169 724 5) Chen et al. (2015), Terazosin activates Pgk1 and HSP90 to promote stress resistance; Nat. Chem. Biol., 11 19
Properties of Terazosin hydrochloride
Melting point: | 261-263°C |
storage temp. | Inert atmosphere,2-8°C |
solubility | H2O: 25 mg/mL |
form | powder |
color | white to off-white |
Water Solubility | Soluble in water at 20mg/ml. Also soluble in methanol or ethanol. |
Stability: | Stable for 2 years as supplied. Solutions in distilled water may be stored at -20° for up to 3 months. |
CAS DataBase Reference | 63074-08-8(CAS DataBase Reference) |
Safety information for Terazosin hydrochloride
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral |
Precautionary Statement Codes |
P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P501:Dispose of contents/container to..… |
Computed Descriptors for Terazosin hydrochloride
Abamectin manufacturer
Synthokem Labs Private Limited
Biophore India Pharmaceuticals Pvt Ltd
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
63074-08-8 Terazosin HCL 98%View Details
63074-08-8 -
Terazosin hydrochloride 99%View Details
-
Terazosin hydrochloride 98%View Details
63074-08-8 -
Terazosin hydrochloride 63074-08-8 98%View Details
63074-08-8 -
Terazosin hydrochloride 95% CAS 63074-08-8View Details
63074-08-8 -
Terazosin hydrochloride CAS 63074-08-8View Details
63074-08-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Lithium ClavulanateView Details
61177-44-4